CLIVION INC. – Trademark Portfolio

Entity Type: 03

CLIVION INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include 9 OPTI NINE and VISTA V 1 GLAMOUR. The owner is based in EL MONTE, CA.

10423 VALLEY BLVD., #F

EL MONTE, CA 91731

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CLIVION INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (12 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CLIVION INC. have?

CLIVION INC. has 13 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 abandoned, 9 cancelled.

What trademark classes does CLIVION INC. file in?

CLIVION INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are CLIVION INC.'s most well-known trademarks?

CLIVION INC.'s registered trademark portfolio includes well-known marks such as 9 OPTI NINE and VISTA V 1 GLAMOUR. These are among 2 currently registered trademarks in the portfolio.

What is CLIVION INC.'s trademark registration success rate?

CLIVION INC. has a 17% trademark registration rate, with 2 out of 12 resolved applications resulting in successful registration. Currently, 1 application is pending review.